Abbott to Develop CDx for AstraZeneca Asthma Drug – GenomeWeb

Abbott to Develop CDx for AstraZeneca Asthma Drug
GenomeWeb
NEW YORK (GenomeWeb) – AstraZeneca has inked an agreement with Abbott to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the investigational therapy, tralokinumab, developed by …
AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma PatientsStreetInsider.com
Diagnostic Tests for Biologic Asthma Therapy Under DevelopmentPharmacy Times
Drugmaker dives into personalized medicine for asthma, heart diseaseHealthcare Packaging
Cambridge News –London South East
all 8 news articles »

View full post on asthma – Google News

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients – StreetInsider.com

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients
StreetInsider.com
AstraZeneca (NYSE: AZN) announced that it has entered an agreement with Abbott (NYSE: ABT), a global healthcare company, to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the …
AstraZeneca Enters Companion Diagnostic Test Deal With AbbottLondon South East

all 3 news articles »

View full post on asthma – Google News

SkyePharma falls as Abbott gets shot of asthma drug – This is London


Genetic Engineering News

SkyePharma falls as Abbott gets shot of asthma drug
This is London
Drugmaker SkyePharma today saw its shares plunge 5% after pharmaceuticals giant Abbott Laboratories ended the deal to sell its asthma drug Flutiform in
SkyePharma loses US partnerGrowthBusiness.co.uk
Abbott bows out of Flutiform pactFierceBiotech
Abbott Returns US Flutiform Rights to SkyePharma after Negative FDA FeedbackGenetic Engineering News
ShareCast –Reuters –Wall Street Journal
all 14 news articles »

View full post on asthma – Google News